Steven E Finkelstein

Summary

Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Country: USA

Publications

  1. ncbi Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients
    Steven E Finkelstein
    H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    Int J Radiat Oncol Biol Phys 82:924-32. 2012
  2. ncbi Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma
    Steven E Finkelstein
    Immunotherapy Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    J Immunother 33:817-27. 2010
  3. ncbi Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy
    Sarah E Hoffe
    Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 17:100-10. 2010
  4. ncbi Systemic therapy for advanced hepatocellular carcinoma: past, present, and future
    Jennifer L Giglia
    Gastrointestinal Tumor Program, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 17:120-9. 2010

Detail Information

Publications4

  1. ncbi Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients
    Steven E Finkelstein
    H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    Int J Radiat Oncol Biol Phys 82:924-32. 2012
    ....
  2. ncbi Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma
    Steven E Finkelstein
    Immunotherapy Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    J Immunother 33:817-27. 2010
    ..Pretreatment assessment of DC phenotypic or maturational status may be a starting point to predicting response to high-dose IL-2 cytokine immunotherapy in patients with melanoma and kidney cancer...
  3. ncbi Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy
    Sarah E Hoffe
    Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 17:100-10. 2010
    ..Its incidence is expected to increase in North America secondary to the increasing incidence of patients who develop hepatitis C. Patients who ultimately develop cirrhosis have an increased risk of developing hepatocellular carcinoma...
  4. ncbi Systemic therapy for advanced hepatocellular carcinoma: past, present, and future
    Jennifer L Giglia
    Gastrointestinal Tumor Program, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 17:120-9. 2010
    ..While responses to traditional chemotherapeutic agents have been documented, significant survival benefit is debatable...